1. Home
  2. DUOT vs SAVA Comparison

DUOT vs SAVA Comparison

Compare DUOT & SAVA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • DUOT
  • SAVA
  • Stock Information
  • Founded
  • DUOT 1990
  • SAVA 1998
  • Country
  • DUOT United States
  • SAVA United States
  • Employees
  • DUOT N/A
  • SAVA N/A
  • Industry
  • DUOT Computer Software: Prepackaged Software
  • SAVA Biotechnology: Pharmaceutical Preparations
  • Sector
  • DUOT Technology
  • SAVA Health Care
  • Exchange
  • DUOT Nasdaq
  • SAVA Nasdaq
  • Market Cap
  • DUOT 66.3M
  • SAVA 70.5M
  • IPO Year
  • DUOT N/A
  • SAVA N/A
  • Fundamental
  • Price
  • DUOT $7.82
  • SAVA $2.10
  • Analyst Decision
  • DUOT Strong Buy
  • SAVA Buy
  • Analyst Count
  • DUOT 2
  • SAVA 3
  • Target Price
  • DUOT $11.50
  • SAVA $54.50
  • AVG Volume (30 Days)
  • DUOT 125.2K
  • SAVA 1.3M
  • Earning Date
  • DUOT 05-15-2025
  • SAVA 05-08-2025
  • Dividend Yield
  • DUOT N/A
  • SAVA N/A
  • EPS Growth
  • DUOT N/A
  • SAVA N/A
  • EPS
  • DUOT N/A
  • SAVA N/A
  • Revenue
  • DUOT $11,162,390.00
  • SAVA N/A
  • Revenue This Year
  • DUOT $296.46
  • SAVA N/A
  • Revenue Next Year
  • DUOT $43.11
  • SAVA N/A
  • P/E Ratio
  • DUOT N/A
  • SAVA N/A
  • Revenue Growth
  • DUOT 89.27
  • SAVA N/A
  • 52 Week Low
  • DUOT $2.03
  • SAVA $1.15
  • 52 Week High
  • DUOT $9.27
  • SAVA $42.20
  • Technical
  • Relative Strength Index (RSI)
  • DUOT 52.82
  • SAVA 58.24
  • Support Level
  • DUOT $7.51
  • SAVA $1.96
  • Resistance Level
  • DUOT $9.27
  • SAVA $2.22
  • Average True Range (ATR)
  • DUOT 0.85
  • SAVA 0.15
  • MACD
  • DUOT -0.03
  • SAVA 0.00
  • Stochastic Oscillator
  • DUOT 34.12
  • SAVA 51.09

About DUOT Duos Technologies Group Inc.

Duos Technologies Group Inc operating under its brand name duostech, designs, develops, deploys and operates intelligent technology solutions supporting rail, logistics and intermodal businesses that streamline operations, improve safety and reduce costs. The company's main offering, the Railcar Inspection Portal (RIP), provides both freight and transit railroad customers and select government agencies the ability to conduct fully automated railcar inspections of trains while they are moving at full speed. It has also developed the Automated Logistics Information System (ALIS) which automates gatehouse operations where transport trucks enter and exit large logistics and intermodal facilities. Its segments are Rail, Commercial, Governments, Banking and AI.

About SAVA Cassava Sciences Inc.

Cassava Sciences Inc is a clinical-stage biotechnology company engaged in developing a scientific approach for the treatment and detection of Alzheimer's disease. Its therapeutic product candidate is called simufilam, and it is a novel treatment for Alzheimer's disease; and investigational diagnostic product candidate is called SavaDx and it is a novel way to detect the presence of Alzheimer's disease from a small sample of blood, possibly years before the overt appearance of clinical symptoms. It is currently conducting two randomized placebo-controlled Phase 3 clinical trials of oral simufilam in patients with Alzheimer's disease dementia. It has one business segment: the development of novel drugs and diagnostics.

Share on Social Networks: